A new federal analysis has offered reassuring findings regarding the safety of infant formula in the U.S., reporting "reassuringly low levels" of heavy metals, pesticides, and other potential contaminants.

Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of phase one clinical trials and applications to the FDA at the end of the trial.